Influenza
Section Editor(s): Ronald Ellis, Biotech and Biopharma, Jerusalem, IL
Influenza vaccine, research, development, preclinical, clinical, safety, biotechnology, epidemiology, cost, and economics.
Filters
Show filters
More subjects within
No subjects within
Selected filters
Clear all filters
- Letter to the Editor Remove selected filter:
- Human Vaccines & Immunotherapeutics
- Influenza
Modify your search
Human Vaccines & Immunotherapeutics sections
-
Showing 1-2 of 2 results for search:
Filters